
Suzhou Kematek Inc. specializes in the production and distribution of various ceramic parts. Its product portfolio includes advanced items such as aluminum nitride substrates and insulators, E-chucks, heating elements, components for flat panel display equipment, and precision injection-molded ceramic parts. Beyond manufacturing, Kematek delivers critical services, including surface finishing, component refurbishment, specialized manufacturing and reconditioning for display and single-wafer chamber components, and expert ceramic injection molding. The company caters to a broad spectrum of sectors, such as semiconductors, electronics, renewable energy, automotive, healthcare, industrial machinery, the oil and gas industry, precision measurement, and aerospace. Established in 2009, this enterprise operates from its headquarters in Suzhou, China.
Suzhou Kematek Inc trades as 301611.SZ on SHZ. The company is classified in Basic Materials / Other Precious Metals and reports in CNY.
The current profile places the business in Other Precious Metals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Suzhou Kematek Inc can be compared against peers such as Sichuan New Energy Power Company Limited, Advanced Technology & Materials Co., Ltd., Sichuan Yahua Industrial Group Co., Ltd., Shandong Sinocera Functional Material Co., Ltd., Weihai Guangwei Composites Co., Ltd., POCO Holding Co., Ltd..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $46.56B, beta of 1.47, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
301611.SZ currently shows total debt of N/A and beta of 1.47. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.kematek.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.